*Assistant Professor of Clinical Medicine (Neurology), Dartmouth Hitchcock Medical Center, Hinman Box 7525, Hanover, New Hampshire 03756; (603) 646-8664.
Dihydroergotamine Suppositories in a Headache Clinic
Article first published online: 20 MAY 2005
Headache: The Journal of Head and Face Pain
Volume 31, Issue 7, pages 465–466, July 1991
How to Cite
Ward, T. N. and Scott, G. (1991), Dihydroergotamine Suppositories in a Headache Clinic. Headache: The Journal of Head and Face Pain, 31: 465–466. doi: 10.1111/j.1526-4610.1991.hed3107465.x
- Issue published online: 20 MAY 2005
- Article first published online: 20 MAY 2005
- Accepted for Publication: June 3, 1991.
- Cited By
Dihydroergotamine (DHE) is available in the United States for parenteral use. We report a preliminary trial of DHE suppositories in an outpatient headache clinic setting. Dihydroergotamine suppositories may be appropriate for patients with catamenial migraine and classic migraine in particular.